These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7788990)

  • 41. Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility study.
    Zhang X; Xin J; Shi Y; Xu W; Yu S; Yang Z; Liu C; Cao L; Guo Q
    Nucl Med Biol; 2015 Mar; 42(3):250-5. PubMed ID: 25530210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The preparation of 99mTc-NGA instant lyophilized kit for hepatic imaging].
    Guan C; Chen Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):429-32. PubMed ID: 8150449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. (99m)Tc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of a single sample plasma and hepatic clearance of (99m)Tc-HEPIDA for assessment of hepatic parenchyma performance.
    Surma MJ; Frieske I; Jencz K; Kuźmierek J
    Nucl Med Rev Cent East Eur; 2006; 9(2):125-31. PubMed ID: 17304475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of congenital hepatic fibrosis: usefulness of hepatobiliary scintigraphy.
    Masuda Y; Sawa H; Kim OH; Fukuda T; Ochi H; Kanayamma Y
    Clin Nucl Med; 1980 Aug; 5(8):359-61. PubMed ID: 7398168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictability of
    Kato A; Nakamoto Y; Ishimori T; Seo S; Uemoto S; Togashi K
    AJR Am J Roentgenol; 2018 Jan; 210(1):158-165. PubMed ID: 29023153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
    Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
    Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent hepatitis C after living donor liver transplantation detected by Tc-99m GSA liver scintigraphy.
    Kaibori M; Ha-Kawa SK; Uchida Y; Ishizaki M; Hijikawa T; Saito T; Imamura A; Hirohara J; Uemura Y; Tanaka K; Kamiyama Y
    Dig Dis Sci; 2006 Nov; 51(11):2013-7. PubMed ID: 16977504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissociation of reticuloendothelial cell and hepatocyte functions in alcoholic liver disease: a clinical study with a new Tc-99m-labeled hepatobiliary agent.
    Rao BK; Weir GJ; Lieberman LM
    Clin Nucl Med; 1981 Jul; 6(7):289-94. PubMed ID: 7237873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The utility of quantitative 99mTc-GSA liver scintigraphy in the evaluation of hepatic functional reserve: comparison with 99mTc-PMT and 99mTc-Sn colloid].
    Shuke N; Aburano T; Nakajima K; Yokoyama K; Sun BF; Matsuda H; Muramori A; Michigishi T; Tonami N; Hisada K
    Kaku Igaku; 1992 May; 29(5):573-84. PubMed ID: 1434071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of
    Mitsunaga T; Higashimoto Y; Saito T; Iwai J
    J Pediatr Surg; 2017 Dec; 52(12):1925-1929. PubMed ID: 28943134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic uptake of Tc-99m DPD on bone scintigraphy: the influence of the interval with gadolinium-containing contrast of MRI.
    Pak K; Kim SJ; Kim IJ; Suh KT
    Clin Nucl Med; 2012 Feb; 37(2):134-6. PubMed ID: 22228334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of (99m)Tc-HEPIDA and (99m)Tc-MBrIDA from the standpoint of hepatic clearance determination-- preliminary communication.
    Surma MJ; Deroń Z; Frieske I; Pietrzak-Stelmasiak E; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2009; 12(2):72-7. PubMed ID: 20235057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy.
    de Graaf W; van Lienden KP; van Gulik TM; Bennink RJ
    J Nucl Med; 2010 Feb; 51(2):229-36. PubMed ID: 20080899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic functional reserve in patients with biliary malignancies: an assessment by technetium 99m galactosyl human serum albumin hepatic scintigraphy.
    Fukunaga K; Todoroki T; Takada Y; Otsuka M; Kawamoto T; Fukao K
    Int Surg; 1999; 84(3):199-203. PubMed ID: 10533776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the residual functional reserve and the early regeneration after the hepatic resection using asialoglycoprotein receptor imaging agent].
    Toyama H; Ito K; Komori Y; Sugioka A; Shibata K; Komai S; Fujiwara T; Ishikawa E; Tomita K; Fujii N
    Kaku Igaku; 1995 Mar; 32(3):323-9. PubMed ID: 7739162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis.
    Tomiguchi S; Kira T; Oyama Y; Nabeshima M; Nakashima R; Tsuji A; Kojima A; Takahashi M; Yoshimatsu S; Sagara K
    Clin Nucl Med; 1995 Aug; 20(8):717-20. PubMed ID: 7586877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A new liver function test using the asialoglycoprotein-receptor system on the liver cell membrane: I. Evaluation of liver imaging using Tc-99m-neoglycoprotein].
    Kubota Y; Kojima M; Hazama H; Kawa S; Nakazawa M; Nishiyama Y; Nakagawa S; Murase T; Okuno H; Naitoh Y
    Kaku Igaku; 1986 Jul; 23(7):899-905. PubMed ID: 3784119
    [No Abstract]   [Full Text] [Related]  

  • 58. Distinct hepatic retention of Tc-99m IDA in arteriohepatic dysplasia (Alagille syndrome).
    Aburano T; Yokoyama K; Takayama T; Tonami N; Hisada K
    Clin Nucl Med; 1989 Dec; 14(12):874-6. PubMed ID: 2605841
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.